SCHEMBL20434634

SCHEMBL20434634

C#COc1ccc2c(c1)[nH]c1cc(C)ccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 6/20 0.51
▸ RXFP1 Q9HBX9 2/20 0.41
▸ DYRK1A Q13627 2/20 0.40
▸ KDM4E B2RXH2 5/20 0.38
▸ ALDH1A1 P00352 3/20 0.37
▸ PIM3 Q86V86 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ DYRK3 O43781 1/20 0.37
▸ CCNT1 O60563 1/20 0.37
▸ CCNB2 O95067 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CDK1 P06493 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ ADRA2A P08913 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CCNB1 P14635 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ ADRA2B P18089 1/20 0.37
▸ ADRA2C P18825 1/20 0.37
▸ CCNA2 P20248 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20438861 0.85 KDM4E (0.52) RXFP1DYRK1AKDM4EALDH1A1PIM3
SCHEMBL6009651 0.79 KDM4E (0.59) KIF11RXFP1DYRK1AKDM4EALDH1A1
SCHEMBL29518339 0.78 KIF11 (0.78) KIF11RXFP1KDM4EALDH1A1PIM3
SCHEMBL4256780 0.78 KIF11 (0.78) KIF11RXFP1KDM4EALDH1A1PIM3
SCHEMBL20434643 0.77 KIF11 (0.51) KIF11RXFP1DYRK1AKDM4EALDH1A1
SCHEMBL20434641 0.75 KIF11 (0.53) KIF11DYRK1AKDM4EALDH1A1HSD17B10
SCHEMBL13828017 0.73 KIF11 (0.72) KIF11RXFP1PIM3ACHEMAPT
SCHEMBL20434631 0.72 KIF11 (0.50) KIF11RXFP1DYRK1AKDM4EALDH1A1
SCHEMBL14286881 0.71 ACHE (0.48) ALDH1A1CYP1A2CYP3A4ACHEMAPT
7-Methoxy-3-Methylcarbazole SCHEMBL31214611 0.71 KDM4E (0.67) KIF11RXFP1DYRK1AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180215712-A1 SMALL MOLECULE ANDROGEN RECEPTOR INHIBITORS AND METHODS OF USE THEREOF GEORGETOWN UNIVERSITY (US) 2018-08-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180215712-A1 SMALL MOLECULE ANDROGEN RECEPTOR INHIBITORS AND METHODS OF USE THEREOF AR, KLK3, BRDT KIF11 2408/4885RXFP1 1281/4885DYRK1A 2487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback